Jeff Johnson
Stock Analyst at Robert W. Baird
(4.49)
# 1,105
Out of 5,004 analysts
617
Total ratings
49.4%
Success rate
9.7%
Average return
Main Sectors:
Stocks Rated by Jeff Johnson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BBNX Beta Bionics | Reiterated: Hold | $14 → $16 | $21.51 | -25.62% | 8 | Sep 15, 2026 | |
| COO The Cooper Companies | Downgraded: Hold | $85 → $61 | $55.38 | +10.15% | 56 | Sep 10, 2026 | |
| XRAY DENTSPLY SIRONA | Reiterated: Hold | $14 → $15 | $9.40 | +59.57% | 54 | Aug 7, 2026 | |
| NVST Envista Holdings | Reiterated: Buy | $31 → $34 | $23.95 | +41.96% | 38 | Aug 6, 2026 | |
| PODD Insulet | Reiterated: Buy | $248 → $175 | $136.13 | +28.55% | 46 | Aug 6, 2026 | |
| ZBH Zimmer Biomet Holdings | Reiterated: Hold | $92 → $104 | $91.04 | +14.24% | 38 | Aug 6, 2026 | |
| HSIC Henry Schein | Reiterated: Buy | $97 → $109 | $86.38 | +26.19% | 57 | Aug 5, 2026 | |
| DXCM DexCom | Reiterated: Buy | $80 → $105 | $86.62 | +21.22% | 61 | Jul 31, 2026 | |
| INMD InMode | Reiterated: Hold | $14 → $17 | $14.26 | +19.21% | 39 | Jul 14, 2026 | |
| ENOV Enovis | Reiterated: Buy | $45 → $37 | $18.46 | +100.43% | 15 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | CHF 78.40 → CHF 74.28 | CHF 53.30 | +39.36% | 33 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $437 → $385 | $272.36 | +41.36% | 37 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $205 → $218 | $146.78 | +48.52% | 66 | Feb 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $18 → $30 | $15.72 | +90.84% | 60 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $43.92 | n/a | 1 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $67 | $2.87 | n/a | 1 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $42 → $49 | - | n/a | 6 | Dec 4, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $99.74 | n/a | 1 | Apr 11, 2016 |
Beta Bionics
Sep 15, 2026
Reiterated: Hold
Price Target: $14 → $16
Current: $21.51
Upside: -25.62%
The Cooper Companies
Sep 10, 2026
Downgraded: Hold
Price Target: $85 → $61
Current: $55.38
Upside: +10.15%
DENTSPLY SIRONA
Aug 7, 2026
Reiterated: Hold
Price Target: $14 → $15
Current: $9.40
Upside: +59.57%
Envista Holdings
Aug 6, 2026
Reiterated: Buy
Price Target: $31 → $34
Current: $23.95
Upside: +41.96%
Insulet
Aug 6, 2026
Reiterated: Buy
Price Target: $248 → $175
Current: $136.13
Upside: +28.55%
Zimmer Biomet Holdings
Aug 6, 2026
Reiterated: Hold
Price Target: $92 → $104
Current: $91.04
Upside: +14.24%
Henry Schein
Aug 5, 2026
Reiterated: Buy
Price Target: $97 → $109
Current: $86.38
Upside: +26.19%
DexCom
Jul 31, 2026
Reiterated: Buy
Price Target: $80 → $105
Current: $86.62
Upside: +21.22%
InMode
Jul 14, 2026
Reiterated: Hold
Price Target: $14 → $17
Current: $14.26
Upside: +19.21%
Enovis
May 8, 2026
Reiterated: Buy
Price Target: $45 → $37
Current: $18.46
Upside: +100.43%
May 7, 2026
Reiterated: Buy
Price Target: CHF 78.40 → CHF 74.28
Current: CHF 53.30
Upside: +39.36%
May 1, 2026
Reiterated: Buy
Price Target: $437 → $385
Current: $272.36
Upside: +41.36%
Feb 5, 2026
Reiterated: Buy
Price Target: $205 → $218
Current: $146.78
Upside: +48.52%
Dec 16, 2025
Upgraded: Buy
Price Target: $18 → $30
Current: $15.72
Upside: +90.84%
Dec 21, 2023
Reiterated: Buy
Price Target: n/a
Current: $43.92
Upside: n/a
May 5, 2023
Reiterated: Buy
Price Target: $67
Current: $2.87
Upside: n/a
Dec 4, 2017
Reiterated: Hold
Price Target: $42 → $49
Current: -
Upside: n/a
Apr 11, 2016
Reiterated: Hold
Price Target: n/a
Current: $99.74
Upside: n/a